Research

In previous posts, we’ve covered the importance of COVID-19 testing for helping to contain the impact of both new disease variants and breakthrough cases for vaccinated individuals. With the global rise of variant B.1.617.2, otherwise known as the delta variant variant, these concerns are becoming very real indeed. While it’s not time for panic, this is the perfect time to get informed about the delta variant and the risks it poses.

Since March 2020, the Food and Drug Administration (FDA) has granted Emergency Use Authorizations (EUAs) for dozens of Real-Time Polymerase Chain Reaction (RT-PCR) diagnostic tests to identify patients infected with SARS-CoV-2, the novel SARS coronavirus strain of 2019 (COVID-19).